[HTML][HTML] Preclinical models of nontuberculous mycobacteria infection for early drug discovery and vaccine research

E Rampacci, V Stefanetti, F Passamonti… - Pathogens, 2020 - mdpi.com
Nontuberculous mycobacteria (NTM) represent an increasingly prevalent etiology of soft
tissue infections in animals and humans. NTM are widely distributed in the environment and …

Preclinical Models of Nontuberculous Mycobacteria Infection for Early Drug Discovery and Vaccine Research

E Rampacci, V Stefanetti, F Passamonti… - …, 2020 - search.proquest.com
Nontuberculous mycobacteria (NTM) represent an increasingly prevalent etiology of soft
tissue infections in animals and humans. NTM are widely distributed in the environment and …

Preclinical Models of Nontuberculous Mycobacteria Infection for Early Drug Discovery and Vaccine Research.

E Rampacci, V Stefanetti, F Passamonti… - …, 2020 - search.ebscohost.com
Nontuberculous mycobacteria (NTM) represent an increasingly prevalent etiology of soft
tissue infections in animals and humans. NTM are widely distributed in the environment and …

Preclinical Models of Nontuberculous Mycobacteria Infection for Early Drug Discovery and Vaccine Research

E Rampacci, V Stefanetti, F Passamonti… - PATHOGENS, 2020 - research.unipg.it
Nontuberculous mycobacteria (NTM) represent an increasingly prevalent etiology of soft
tissue infections in animals and humans. NTM are widely distributed in the environment and …

Preclinical Models of Nontuberculous Mycobacteria Infection for Early Drug Discovery and Vaccine Research

E Rampacci, V Stefanetti… - Pathogens (Basel …, 2020 - pubmed.ncbi.nlm.nih.gov
Nontuberculous mycobacteria (NTM) represent an increasingly prevalent etiology of soft
tissue infections in animals and humans. NTM are widely distributed in the environment and …

[PDF][PDF] Preclinical Models of Nontuberculous Mycobacteria Infection for Early Drug Discovery and Vaccine Research

E Rampacci, V Stefanetti, F Passamonti… - researchgate.net
Nontuberculous mycobacteria (NTM) represent an increasingly prevalent etiology of soft
tissue infections in animals and humans. NTM are widely distributed in the environment and …

Preclinical models of nontuberculous mycobacteria infection for early drug discovery and vaccine research.

E Rampacci, V Stefanetti, F Passamonti… - 2020 - cabidigitallibrary.org
Nontuberculous mycobacteria (NTM) represent an increasingly prevalent etiology of soft
tissue infections in animals and humans. NTM are widely distributed in the environment and …

[PDF][PDF] Preclinical Models of Nontuberculous Mycobacteria Infection for Early Drug Discovery and Vaccine Research

E Rampacci, V Stefanetti, F Passamonti… - academia.edu
Nontuberculous mycobacteria (NTM) represent an increasingly prevalent etiology of soft
tissue infections in animals and humans. NTM are widely distributed in the environment and …

[PDF][PDF] Preclinical Models of Nontuberculous Mycobacteria Infection for Early Drug Discovery and Vaccine Research

E Rampacci, V Stefanetti, F Passamonti… - pdfs.semanticscholar.org
Nontuberculous mycobacteria (NTM) represent an increasingly prevalent etiology of soft
tissue infections in animals and humans. NTM are widely distributed in the environment and …

Preclinical Models of Nontuberculous Mycobacteria Infection for Early Drug Discovery and Vaccine Research.

E Rampacci, V Stefanetti, F Passamonti… - Pathogens (Basel …, 2020 - europepmc.org
Nontuberculous mycobacteria (NTM) represent an increasingly prevalent etiology of soft
tissue infections in animals and humans. NTM are widely distributed in the environment and …